| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/09/2003 | CN1408423A Medicine for curing hepatitis B |
| 04/09/2003 | CN1408387A Tea essence compound medicine and its preparing method |
| 04/09/2003 | CN1408381A Bear gall, liver protecting oral liquor and its producing method |
| 04/09/2003 | CN1408378A 带状疱疹酊 Shingles tincture |
| 04/09/2003 | CN1408377A Herpes zoster liquid |
| 04/09/2003 | CN1408358A Recipe component of zinc gluconate colloid nose spray |
| 04/09/2003 | CN1408354A Compound preparation containing rifampicin and isoniazid and its preparing method |
| 04/09/2003 | CN1408349A Foot-and-mouth disease gene engineering polypeptide vaccine and its preparing method |
| 04/09/2003 | CN1408348A Anti-cancer medicine with elemene as raw material and its preparing method |
| 04/09/2003 | CN1408336A Complex room container preparation |
| 04/09/2003 | CN1104909C Composition for prevention and treatment of HIV-1 infection comprising at least two different HIV-1 reverse transcriptase inhibitors |
| 04/09/2003 | CN1104907C Vibrio cholerae 01 (CVD111) and Non-01 (CVD112 and CVD112 RM) serogroup vaccine strain and methods of making same |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104899C Injectable quinolone formulations |
| 04/09/2003 | CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor |
| 04/08/2003 | US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6545058 Contains terpenoid as active ingredient |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545051 Antibacterial hydroxamic acid derivatives |
| 04/08/2003 | US6545050 Aryl sulphonamide amino acid esters and analogues |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545021 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 04/08/2003 | US6545015 Useful in therapy of bacterial infections, fungal infections |
| 04/08/2003 | US6545007 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 04/08/2003 | US6545001 Antiviral nucleoside analogues |
| 04/08/2003 | US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein |
| 04/08/2003 | US6544991 Compositions and methods for treating bacterial infections |
| 04/08/2003 | US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors |
| 04/08/2003 | US6544961 Especially for treatment of infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors. |
| 04/08/2003 | US6544780 Adenovirus vector with multiple expression cassettes |
| 04/08/2003 | US6544728 Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2 |
| 04/08/2003 | US6544561 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 04/08/2003 | US6544530 Stable oil-in-glycerin emulsion |
| 04/08/2003 | US6544528 For protecting cats from infection by a broad range of feline leukemia virus |
| 04/08/2003 | US6544527 Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region |
| 04/08/2003 | US6544526 For immunization of horses |
| 04/08/2003 | US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/08/2003 | US6544521 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150 |
| 04/08/2003 | US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same |
| 04/08/2003 | US6544518 Vaccines |
| 04/08/2003 | US6544516 Treating with anitbodies for bactericidal activity against enterococci |
| 04/08/2003 | US6544514 Compositions comprising, as the main ingredient, allogenic activated-C4+ cells and method for producing and using the same |
| 04/08/2003 | US6544510 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/08/2003 | US6544509 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/08/2003 | US6544508 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 04/08/2003 | CA2275323C Asymmetric synthesis of benzoxazinones |
| 04/08/2003 | CA2224983C Triazole antifungal agents |
| 04/08/2003 | CA2172245C Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein |
| 04/08/2003 | CA2112165C Bicyclic amine derivatives |
| 04/08/2003 | CA2107732C Retrovirus from the hiv group and its use |
| 04/08/2003 | CA2098098C Tetrapeptides deriving from dalbaheptide antibiotics |
| 04/08/2003 | CA2086756C Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections |
| 04/08/2003 | CA2061601C Methods and compositions for the treatment of infection and control of flora |
| 04/08/2003 | CA2050300C Tnf-inhibiting proteins and the preparation thereof |
| 04/04/2003 | WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/04/2003 | CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/03/2003 | WO2003027319A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027255A2 Anti-fusion assay |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027098A1 Benzimidazole compound, process for producing the same, and use thereof |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027083A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 04/03/2003 | WO2003027077A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 04/03/2003 | WO2003027076A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | WO2003026767A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 04/03/2003 | WO2003026693A2 Inhibitors of costimulation by 0x40 and their use against infectious diseases |
| 04/03/2003 | WO2003026691A2 Use of hmgb1 for the activation of dendritic cells |
| 04/03/2003 | WO2003026690A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 04/03/2003 | WO2003026688A1 Biphasic liposomes containing immunogen and cpg, for stimulating an immune response |
| 04/03/2003 | WO2003026686A1 Potentiating the therapeutic effects of interferons |
| 04/03/2003 | WO2003026681A1 Inactivation of papillomavirus |
| 04/03/2003 | WO2003026675A1 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 04/03/2003 | WO2003026674A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 04/03/2003 | WO2003026671A1 Method of treating middle ear infections |
| 04/03/2003 | WO2003026669A1 Monobactam antibacterial compounds and methods of use thereof |
| 04/03/2003 | WO2003026663A1 Process for making substituted pyrazoles |
| 04/03/2003 | WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 04/03/2003 | WO2003026647A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 04/03/2003 | WO2003026646A1 Photodynamic porphyrin antimicrobial agents |
| 04/03/2003 | WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 04/03/2003 | WO2003026579A2 Combination therapies for immune mediated diseases |
| 04/03/2003 | WO2003026572A2 Crystalline forms of ertapenem sodium |
| 04/03/2003 | WO2003026568A2 Androstanes as androgen receptor modulators |
| 04/03/2003 | WO2003026479A2 Methods of suppressing microglial activation |
| 04/03/2003 | WO2003026420A1 Bactericidal solutions |
| 04/03/2003 | WO2003011859A3 Oxazolidinone derivatives as antibacterial agents |